Olympus Finalizes Divestiture of its Orthopedic Business

Olympus has successfully completed the transfer of its orthopedic business to entities established by Polaris Capital. The deal, which includes the sale of all shares of its subsidiaries Olympus Terumo Biomaterials Corporation and FH Ortho, is expected to have an immaterial impact on Olympus’s consolidated operating profit for the fiscal year...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0